US to invest $160m in cancer partnership

(Reuters) - The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer.

US to invest $160m in cancer partnership

Funds will be backed up with $55m from 11 companies to advance new cancer treatments that harness the immune system

Tue 17 Oct 17 from Chemistry World

Big pharma joins NIH’s Cancer Moonshot for a biomarker hunt

The National Institutes of Health announces a five-year, $215 million partnership with 11 companies to establish biomarkers for immunotherapies

Thu 12 Oct 17 from CandEN

U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research

(Reuters) - The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight ...

Thu 12 Oct 17 from Reuters

NIH partners 11 drugmakers to accelerate cancer therapy research

(Reuters) - The National Institutes of Health said on Thursday it had partnered 11 biopharma companies to help advance a new class of drugs that uses the body's immune system to fight cancer. ...

Thu 12 Oct 17 from Reuters Health

  • Pages: 1

Bookmark

Bookmark and Share